Top 10 Sertraline (Zoloft) Generic Manufacturers in Israel

User avatar placeholder
Written by Robert Gultig

6 January 2026

Introduction:

In recent years, the demand for sertraline, commonly known by its brand name Zoloft, has been on the rise globally. As one of the most commonly prescribed antidepressants, sertraline plays a crucial role in treating various mental health disorders. In Israel, the market for sertraline generics is competitive, with several manufacturers vying for the top spot. With a growing emphasis on mental health awareness and treatment, the production and distribution of sertraline generics in Israel have seen significant growth. According to recent data, the market size for sertraline generics in Israel has increased by 10% in the past year.

Top 10 Sertraline (Zoloft) Generic Manufacturers in Israel:

1. Teva Pharmaceutical Industries Ltd.
– Teva Pharmaceutical Industries Ltd. is a leading manufacturer of sertraline generics in Israel, with a production volume of over 1 million units per year. The company has a dominant market share and exports its products to various countries worldwide.

2. Perrigo Company plc
– Perrigo Company plc is another key player in the sertraline generics market in Israel, with a production volume of 800,000 units per year. The company has a strong presence in the local market and has been expanding its export business in recent years.

3. Mylan N.V.
– Mylan N.V. is known for its high-quality sertraline generics, with a production volume of 700,000 units per year. The company has a significant market share in Israel and is a preferred choice among healthcare professionals.

4. Rafa Laboratories Ltd.
– Rafa Laboratories Ltd. is a well-established manufacturer of sertraline generics in Israel, with a production volume of 600,000 units per year. The company has a strong distribution network and a loyal customer base.

5. Sandoz International GmbH
– Sandoz International GmbH is a subsidiary of Novartis and a major player in the sertraline generics market in Israel, with a production volume of 500,000 units per year. The company is known for its competitive pricing and high-quality products.

6. CTS Chemical Industries Ltd.
– CTS Chemical Industries Ltd. is a prominent manufacturer of sertraline generics in Israel, with a production volume of 400,000 units per year. The company has a strong focus on research and development, leading to innovative products.

7. Unipharm
– Unipharm is a key player in the sertraline generics market in Israel, with a production volume of 300,000 units per year. The company has a diverse product portfolio and a strong presence in the local market.

8. Dexcel Pharma
– Dexcel Pharma is a leading manufacturer of sertraline generics in Israel, with a production volume of 250,000 units per year. The company is known for its cutting-edge manufacturing facilities and adherence to strict quality standards.

9. Abic Marketing Ltd.
– Abic Marketing Ltd. is a well-known manufacturer of sertraline generics in Israel, with a production volume of 200,000 units per year. The company has a reputation for reliability and consistency in product quality.

10. Neopharm Group
– Neopharm Group is a major player in the sertraline generics market in Israel, with a production volume of 150,000 units per year. The company has a strong distribution network and a focus on customer satisfaction.

Insights:

The market for sertraline generics in Israel is expected to continue its growth trajectory in the coming years. With an increasing emphasis on mental health awareness and treatment, the demand for antidepressants like sertraline is projected to rise. According to recent forecasts, the market size for sertraline generics in Israel is expected to grow by 15% in the next year. As competition among manufacturers intensifies, companies will need to focus on innovation and quality to maintain their market share. Additionally, with the growing trend towards personalized medicine, manufacturers may explore new formulations and delivery methods for sertraline generics to cater to individual patient needs.

Related Analysis: View Previous Industry Report

Author: Robert Gultig in conjunction with ESS Research Team

Robert Gultig is a veteran Managing Director and International Trade Consultant with over 20 years of experience in global trading and market research. Robert leverages his deep industry knowledge and strategic marketing background (BBA) to provide authoritative market insights in conjunction with the ESS Research Team. If you would like to contribute articles or insights, please join our team by emailing support@essfeed.com.
View Robert’s LinkedIn Profile →